Table of Contents
ISRN Obesity
Volume 2013 (2013), Article ID 584547, 8 pages
http://dx.doi.org/10.1155/2013/584547
Research Article

Age-Related Differences in Response to High-Fat Feeding on Adipose Tissue and Metabolic Profile in ZDSD Rats

1Animal Science, Food and Nutrition, Southern Illinois University, Carbondale, IL 62901-4317, USA
2PreClinOmics Inc., Indianapolis, IN 46268-1649, USA

Received 2 April 2013; Accepted 29 April 2013

Academic Editors: D. Tekin and S. Weitzman

Copyright © 2013 Jeremy E. Davis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Smyth and A. Heron, “Diabetes and obesity: the twin epidemics,” Nature Medicine, vol. 12, no. 1, pp. 75–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Shea, E. W. Randell, and G. Sun, “The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry,” Obesity, vol. 19, no. 3, pp. 624–630, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. P. Wildman, P. Muntner, K. Reynolds et al., “The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004),” Archives of Internal Medicine, vol. 168, no. 15, pp. 1617–1624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Stefan, K. Kantartzis, J. Machann et al., “Identification and characterization of metabolically benign obesity in humans,” Archives of Internal Medicine, vol. 168, no. 15, pp. 1609–1616, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Shin, Y. J. Hyun, O. Y. Kim, J. Y. Kim, Y. Jang, and J. H. Lee, “Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women,” International Journal of Obesity, vol. 30, no. 10, pp. 1529–1534, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Kelishadi, S. R. Cook, M. E. Motlagh et al., “Metabolically obese normal weight and phenotypically obese metabolically normal youths: The CASPIAN Study,” Journal of the American Dietetic Association, vol. 108, no. 1, pp. 82–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Succurro, M. A. Marini, S. Frontoni et al., “Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals,” Obesity, vol. 16, no. 8, pp. 1881–1886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Ross, N. Hemati, K. A. Longo et al., “Inhibition of adipogenesis by Wnt signaling,” Science, vol. 289, no. 5481, pp. 950–953, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kawai, S. Mushiake, K. Bessho et al., “Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha,” Biochemical and Biophysical Research Communications, vol. 363, no. 2, pp. 276–282, 2007. View at Google Scholar
  10. C. N. Bennett, S. E. Ross, K. A. Longo et al., “Regulation of Wnt signaling during adipogenesis,” The Journal of Biological Chemistry, vol. 277, no. 34, pp. 30998–31004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Gustafson, B. Eliasson, and U. Smith, “Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis,” Diabetologia, vol. 53, no. 3, pp. 536–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Luand and D. A. Carson, “Repression of beta-catenin signaling by PPAR gamma ligands,” European Journal of Pharmacology, vol. 636, no. 1–3, pp. 198–202, 2010. View at Google Scholar
  13. A. Vidal-Puig, M. Jimenez-Liñan, B. B. Lowell et al., “Regulation of PPAR γ gene expression by nutrition and obesity in rodents,” Journal of Clinical Investigation, vol. 97, no. 11, pp. 2553–2561, 1996. View at Google Scholar · View at Scopus
  14. J. R. Chen, O. P. Lazarenko, X. Wu et al., “Obesity reduces bone density associated with activation of PPARgamma and suppression of Wnt/beta-catenin in rapidly growing male rats,” PLoS ONE, vol. 5, no. 10, Article ID e13704, 2010. View at Google Scholar
  15. I. Karagiannides, T. Tchkonia, D. E. Dobson et al., “Altered expression of C/EBP family members results in decreased adipogenesis with aging,” American Journal of Physiology, vol. 280, no. 6, pp. R1772–R1780, 2001. View at Google Scholar · View at Scopus
  16. B. M. Schipper, K. G. Marra, W. Zhang, A. D. Donnenberg, and J. P. Rubin, “Regional anatomic and age effects on cell function of human adipose-derived stem cells,” Annals of Plastic Surgery, vol. 60, no. 5, pp. 538–544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. L. Spalding, E. Arner, P. O. Westermark et al., “Dynamics of fat cell turnover in humans,” Nature, vol. 453, no. 7196, pp. 783–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. L. Knittle, K. Timmers, and F. Ginsberg-Fellner, “The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size,” Journal of Clinical Investigation, vol. 63, no. 2, pp. 239–246, 1979. View at Google Scholar · View at Scopus
  19. J. B. Prins and S. O'Rahilly, “Regulation of adipose cell number in man,” Clinical Science, vol. 92, no. 1, pp. 3–11, 1997. View at Google Scholar · View at Scopus
  20. A. Okuno, H. Tamemoto, K. Tobe et al., “Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats,” Journal of Clinical Investigation, vol. 101, no. 6, pp. 1354–1361, 1998. View at Google Scholar · View at Scopus
  21. S. Sugii, P. Olson, D. D. Sears et al., “PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 52, pp. 22504–22509, 2009. View at Google Scholar
  22. P. D. Berk, S. L. Zhou, C. L. Kiang, D. Stump, M. Bradbury, and L. M. Isola, “Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus,” The Journal of Biological Chemistry, vol. 272, no. 13, pp. 8830–8835, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Peterson, “The Zucker Diabetic fatty (ZDF) rat—lessons from a leptin receptor defect diabetic model,” in Animal Models of Diabetes, Frontiers in Research, E. Shafrir, Ed., pp. 103–118, CRC Press, Boca Raton, Fla, USA, 2008. View at Google Scholar
  24. B. Wagoner, D. B. Hausman, and R. B. S. Harris, “Direct and indirect effects of leptin on preadipocyte proliferation and differentiation,” American Journal of Physiology, vol. 290, no. 6, pp. R1557–R1564, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Reinwald, R. G. Peterson, M. R. Allen, and D. B. Burr, “Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models,” American Journal of Physiology, vol. 296, no. 4, pp. E765–E774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. P. C. Hughes and J. M. Tanner, “The assessment of skeletal maturity in the growing rat,” Journal of Anatomy, vol. 106, no. 2, pp. 371–402, 1970. View at Google Scholar · View at Scopus
  27. J. N. Artaza, S. Bhasin, C. Mallidis, W. Taylor, K. Ma, and N. F. Gonzalez-Cadavid, “Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells,” Journal of Cellular Physiology, vol. 190, no. 2, pp. 170–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Gustafson and U. Smith, “Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes,” The Journal of Biological Chemistry, vol. 281, no. 14, pp. 9507–9516, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Shea, E. W. Randell, and G. Sun, “The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry,” Obesity, vol. 19, no. 3, pp. 624–630, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. E. A. Sims, “Characterization of the syndromes of obesity,” in Diabetes Mellitus and Obesity, B. N. Brodoff and S. J. Bleicher, Eds., pp. 219–226, Williams & Wilkins, London, UK, 1982. View at Google Scholar
  31. G. V. Denisand and M. S. Obin, “‘Metabolically healthy obesity’: origins and implications,” Molecular Aspects of Medicine, vol. 34, no. 1, pp. 59–70, 2013. View at Google Scholar
  32. J. Y. Kim, E. Van De Wall, M. Laplante et al., “Obesity-associated improvements in metabolic profile through expansion of adipose tissue,” Journal of Clinical Investigation, vol. 117, no. 9, pp. 2621–2637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. J. De Souza, M. Eckhardt, K. Gagen et al., “Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance,” Diabetes, vol. 50, no. 8, pp. 1863–1871, 2001. View at Google Scholar · View at Scopus
  34. B. Gustafson and U. Smith, “Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases β-catenin levels and leads to cell dedifferentiation and insulin resistance,” The Journal of Biological Chemistry, vol. 285, no. 18, pp. 14031–14041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. T. B. Koenen, C. J. Tack, J. M. Kroese et al., “Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 11, pp. 4453–4457, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. McLaughlin, A. Sherman, P. Tsao et al., “Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis,” Diabetologia, vol. 50, no. 8, pp. 1707–1715, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Fabbrini, F. Magkos, B. S. Mohammed et al., “Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 36, pp. 15430–15435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Srdic, E. Stokic, A. Korac et al., “Morphological characteristics of abdominal adipose tissue in normal-weight and obese women of different metabolic profiles,” Experimental and Clinical Endocrinology & Diabetes, vol. 118, no. 10, pp. 713–718, 2010. View at Publisher · View at Google Scholar
  39. G. P. Ravelli, Z. A. Stein, and M. W. Susser, “Obesity in young men after famine exposure in utero and early infancy,” The New England Journal of Medicine, vol. 295, no. 7, pp. 349–353, 1976. View at Google Scholar · View at Scopus
  40. M. F. Rolland Cachera, M. Deheeger, and F. Bellisle, “Adiposity rebound in children: a simple indicator for predicting obesity,” American Journal of Clinical Nutrition, vol. 39, no. 1, pp. 129–135, 1984. View at Google Scholar · View at Scopus
  41. C. G. Brook, J. K. Lloyd, and O. H. Wolf, “Relation between age of onset of obesity and size and number of adipose cells,” British Medical Journal, vol. 2, no. 5804, pp. 25–27, 1972. View at Google Scholar · View at Scopus
  42. E. Pouteau, S. Turner, O. Aprikian et al., “Time course and dynamics of adipose tissue development in obese and lean Zucker rat pups,” International Journal of Obesity, vol. 32, no. 4, pp. 648–657, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Hotta, N. L. Bodkin, T. A. Gustafson, S. Yoshioka, H. K. Ortmeyer, and B. C. Hansen, “Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARγ, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys,” Journals of Gerontology A, vol. 54, no. 5, pp. B183–B188, 1999. View at Google Scholar · View at Scopus
  44. X. Yang, P. A. Jansson, I. Nagaev et al., “Evidence of impaired adipogenesis in insulin resistance,” Biochemical and Biophysical Research Communications, vol. 317, no. 4, pp. 1045–1051, 2004. View at Google Scholar
  45. P. Isakson, A. Hammarstedt, B. Gustafson, and U. Smith, “Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-α, and inflammation,” Diabetes, vol. 58, no. 7, pp. 1550–1557, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Gustafson, S. Gogg, S. Hedjazifar et al., “Inflammation and impaired adipogenesis in hypertrophic obesity in man,” American Journal of Physiology, vol. 297, no. 5, pp. E999–E1003, 2009. View at Publisher · View at Google Scholar